Scientific Achievements

Introduction In modern medical discourse—particularly in the context of advanced, regenerative, and cell-based therapies—two fundamentally different clinical approaches are often confused: randomized clinical trials (RCTs) and compassionate use . Although both play important roles in the development and application of medical innovation, they serve distinct scientific, ethical, and clinical purposes . Understanding this distinction is essential for patients, families, and cl

BioCells Medical | ClinicalTrials.gov Identifier: NCT07145502 Neuroinflammatory conditions of autoimmune or post-infectious origin represent a complex and often debilitating group of disorders affecting the central nervous system. These syndromes—including autoimmune encephalitis, post-infectious encephalopathies, and neuroinflammatory demyelination—can lead to cognitive impairment, neurological deficits, fatigue, and reduced quality of life. In many patients, standard immuno

BioCells Medical | ClinicalTrials.gov Identifier: NCT07146087 Multiple sclerosis ( MS ) is a chronic, immune-mediated neurological disorder characterized by inflammation, demyelination, and neurodegeneration within the central nervous system. In its progressive forms — particularly secondary progressive MS (SPMS) and primary progressive MS (PPMS) — the disease leads to accumulating disability, impaired mobility, cognitive decline, fatigue, and decreased quality of life for pa

BioCells Medical | ClinicalTrials.gov Identifier: NCT07143656 Amyotrophic lateral sclerosis ( ALS ) is a progressive neurodegenerative condition that affects motor neurons — the nerve cells responsible for controlling voluntary muscle movement. Over time, ALS leads to muscle weakness, difficulties with speech and swallowing, respiratory decline, and significant impairment in daily functioning. Despite extensive research, there remains an urgent need to better understand how t